IMIDS FOUNDATION
DEAD

Serial Number

87576884

Owner

Celgene Corporation

Attorney

Marilyn F. Kelly

Filing Date

Aug 21, 2017

Add to watchlist:

No watchlists yet
View on USPTO

IMIDS FOUNDATION Trademark

Serial Number: 87576884 • Registration: 5538768

IMIDS FOUNDATION is a trademark filed by Celgene Corporation on August 21, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

August 21, 2017

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Cancellation Date

February 28, 2025

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer and immune related diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 28, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 14, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 9, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 9, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 9, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 26, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 20, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 12, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 12, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 12, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 12, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2018 CRFA
ASSIGNED TO LIE
Feb 14, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 28, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 28, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 28, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2017 NWOS
NEW APPLICATION ENTERED
Aug 24, 2017 NWAP